![]() |
|
|
Vol. 282, Issue 2, 866-872, 1997
Faculty of Pharmaceutical Sciences,
| |
Abstract |
|---|
|
|
|---|
Eisai hyperbilirubinemic rat (EHBR) is a mutant strain with a hereditary defect in canalicular multispecific organic anion transporter (cMOAT). We examined the uptake and mutual inhibition of S-(2,4-dinitrophenyl)-glutathione (DNP-SG), which is a typical substrate for cMOAT, and 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) glucuronide (E-glu) with canalicular membrane vesicles (CMV) prepared from Sprague-Dawley (SD) and EHBR rats to investigate the multiplicity of the organic anion transporter. The ATP-dependent uptake by CMV from SD rats had an apparent Km of 17.6 µM for DNP-SG and 5.7 µM for E-glu, whereas the corresponding uptake by CMV from EHBR had an apparent Km of 44.6 µM for E-glu. The effects of E-glu, 4-methylumbelliferone glucuronide (4 MUG), E3040 sulfate (E-sul) and 4-methylumbelliferone sulfate (4 MUS) on the uptake of [3H]DNP-SG were also examined. The uptake of [3H]DNP-SG was inhibited by glucuronides (E-glu and 4 MUG) in a concentration-dependent manner, although it was enhanced by the sulfate conjugates (E-sul and 4 MUS). This enhancement was shown to be caused by an increased DNP-SG affinity for the transporter. In CMV from SD rats, although ATP-dependent uptake of [3H]DNP-SG was almost completely inhibited by E-glu, that of [14C]E-glu was only reduced to about 30% of controls by DNP-SG. On the other hand, in CMV from EHBR, the ATP-dependent uptake of [14C]E-glu was not inhibited at all by DNP-SG. Kinetic analysis indicated that E-glu inhibited DNP-SG uptake competitively. In conclusion: 1) cMOAT recognizes both DNP-SG and E-glu, and another transporter present in SD rats is also involved in E-glu transport along with cMOAT; 2) the latter transporter is kinetically similar to the E-glu transporter present in EHBR; 3) E-sul enhances the uptake of DNP-SG by increasing the affinity of glucuronide for the transporter.
| |
Introduction |
|---|
|
|
|---|
The
primary biliary active excretion process for several organic anions
after conjugation has been designated as "Phase-3" detoxification
(Ishikawa, 1992
) and is one of the hepatic elimination mechanisms for
xenobiotics. Currently, at least three different types of transporters
are considered to be present on the bile canalicular membrane and to
transport xenobiotics and endogenous compounds by primary active
transport driven by cellular ATP hydrolysis. Of these, 1) the first is
selective for bile acids, such as TCA (Adachi et al., 1991
;
Nishida et al., 1991
) which is the main constituent of bile
acid; 2) the second transporter (cMOAT; canalicular multispecific
organic anion transporter) transports organic anions including several
conjugates, such as LTC4 (Ishikawa et
al., 1990
; Sathirakul et al., 1994
), an endogenous
compound, and DNP-SG (Kobayashi et al., 1990
), a
glutathione-conjugate; 3) the third transporter is selective for
amphipathic organic cations including anticancer drugs (Kamimoto
et al., 1989
), called P-glycoprotein, which is the product
of the mdr gene(s) (multidrug resistance). Recent progress in this area
of research has been partly due to the development and use of bile CMV
(Inoue et al., 1983
; Meier et al., 1984
), and by
the discovery of the mutant rats such as the TR
strain (Jansen et al., 1985
) and the EHBR strain
(Mikami et al., 1986
) which have an inherited deficiency in
their biliary excretion of organic anions. With use of such animals,
several organic anions and their conjugates have been reported to be
excreted into the bile via the primary active transporter
which is deficient in mutant rats (Jansen et al., 1985
;
Fernandez-Checa et al., 1992
).
However, our own recent in vivo studies suggest that there
are multiple biliary excretion mechanisms for organic anions
(Sathirakul et al., 1994
; Shimamura et al., 1994
;
Takenaka et al., 1995b
). For example, in EHBR, the biliary
excretion of LG glucuronides was markedly reduced, whereas that of
LG-sulfate was similar to that in normal rats (Shimamura et
al., 1994
). Furthermore, the biliary excretion of E-glu, measured
by liver perfusion, was severely impaired in EHBR, whereas no
significant reduction was seen for the sulfate (E-sul) (Takenaka
et al., 1995b
). This result was confirmed by an in
vitro uptake study with use of CMV prepared from SD rats and EHBR.
The ATP-dependent uptake of DNP-SG, a typical substrate for cMOAT, was
markedly reduced in EHBR, whereas that of E-glu in EHBR remained at
about 30% that in SD rats (Takenaka et al., 1995a
). In
contrast, ATP did not stimulate the uptake of E-sul into CMV and
the uptake of E-sul was similar for SD rats and EHBR (Takenaka et
al., 1995a
). These findings suggest that there is also an
ATP-dependent primary active E-glu transporter in EHBR.
To demonstrate directly the presence of multiple biliary excretion mechanisms for conjugates, we examined the kinetics of the inhibitory effect of E-glu and E-sul on the ATP-dependent uptake of DNP-SG and vice versa.
| |
Materials and Methods |
|---|
|
|
|---|
Materials.
Unlabeled and 14C-labeled
E3040
([2-14C]6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)
benzothiazole dihydrochloride) (specific activity, 50.9 µCi/µmol)
were supplied by Eisai Co., Ltd. (Tsukuba, Japan). Unlabeled and
3H-labeled DNP-SG (50.0 µCi/nmol) was
synthesized as described previously (Kobayashi et al.,
1990
). [3H]TCA (3.47 µCi/nmol) and
[3H]glutathione (50.0 µCi/nmol) were
purchased from New England Nuclear (Boston, MA). The glucuronide and
sulfate of E3040 were prepared by incubating E3040 with rat liver
microsomes and cytosol, respectively, as described previously (Takenaka
et al., 1995b
). ATP, creatine phosphate and creatine
phosphokinase were purchased from Sigma Chemical Co. (St. Louis, MO).
All other chemicals used were commercially available and were reagent
grade.
Preparation of CMV.
CMV were prepared from male SD rats and
EHBR liver as described previously (Kobayashi et al., 1990
).
After suspending them in 50 mM Tris buffer (pH 7.4) containing 250 mM
sucrose, the membrane vesicles were frozen in liquid
N2 and stored at
100°C until used. To check
the purity of the prepared CMV, the activity of
Na+/K+- and
Mg++-ATPases, alkaline phosphatase and leucine
aminopeptidase activities was determined by the method of Scharschmidt
et al. (1979)
, Yachi et al. (1989)
and an leucine
aminopeptidase assay kit (Wako Pure Chemical Industries, Osaka, Japan),
respectively. The activity of the CMV was also checked by measuring the
ATP-dependent uptake of standard substrates,
[3H]TCA (1 µM) and
[3H] DNP-SG (1 µM) for a 2-min incubation
performed at 37°C. Protein concentrations were determined as
described previously (Bradford, 1976
), with the Bio-Rad protein assay
kit with bovine serum albumin as a standard.
Uptake study of [3H]DNP-SG,
[14C]E-glu and
[3H]TCA by CMV.
The uptake study of
[3H]DNP-SG (1 µM; labeled, 0.1 µM;
unlabeled, 0.9 µM), [14C]E-glu (20 µM) and
[3H]TCA (1 µM) was performed as reported
previously (Sathirakul et al., 1994
; Takenaka et
al., 1995a
). The transport medium (10 mM Tris, 250 mM sucrose and
10 mM MgCl2·6H2O, pH 7.4)
contained the ligands, 5 mM ATP and an ATP-regenerating system (10 mM
creatine phosphate and 100 µg/ml of creatine phosphokinase). An
aliquot of transport medium (17-18 µl) was mixed rapidly with the
vesicle suspension (10 µg protein in 2-3 µl). The transport
reaction was stopped by the addition of 1 ml ice-cold buffer containing
250 mM sucrose, 0.1 M NaCl and 10 mM Tris-HCl (pH 7.4). The stopped reaction mixture was filtered through a 0.45-µm HA filter (Millipore Corp., Bedford, MA), and then was washed twice with 5 ml of the stop
solution. The radioactivity retained on the filter and reaction mixture
was combined with scintillation cocktail (Clear-sol I, Nacarai Tesque,
Tokyo, Japan) and measured with a liquid scintillation counter (LS
6000SE, Beckman Instruments, Fullerton, CA). Ligand uptake was
normalized in terms of the amount of membrane protein.
Determination of kinetic parameters. The kinetic parameters for ATP-dependent uptake, obtained by subtracting the value in the absence of ATP from the value in its presence of [3H]DNP-SG, [14C]E-glu and [3H]TCA were estimated according to the following equation:
|
(1) |
|
(2) |
|
|
|
(3) |
|
|
(4) |
|
(5) |
|
(6) |
|
|
(7) |
|
(8) |
/Vo = 1/2)
can be observed, iapp = Ki.
When Km
S, that is, the
substrate concentration is much less than the
Km value, equation 6 becomes:
|
(9) |
| |
Results |
|---|
|
|
|---|
ATP-Dependent Uptake of DNP-SG and E-glu
Time profiles were examined for the uptake of
[3H]DNP-SG and
[14C]E-glu by CMV prepared from SD rats. Marked
ATP-dependence and overshoot phenomena were observed in the uptake of
both compounds (fig. 1). Because uptake
in the presence of 5 mM ATP and the ATP-regenerating system increased
linearly up to 2 min for [3H]DNP-SG and up to 1 min for [14C]E-glu (fig. 1), in the following
analyses the initial uptake rates were calculated with data at 2 min
([3H]DNP-SG) and 1 min
([14C]E-glu), respectively, after the reaction
started.
|
The initial uptake of [3H]DNP-SG and
[14C]E-glu into CMV in the presence and absence
of ATP was measured with various ligand concentrations and the data
were converted into Eadie-Hofstee plots (fig.
2). ATP-dependent uptake (obtained by
subtracting the value in the absence of ATP from that in its presence)
of [3H]DNP-SG by CMV from SD rats provided a
Km value of 17.6 µM and a
Vmax estimate of 1150 pmol/min/mg protein
(fig. 2A). In [14C]E-glu with CMV from SD rats,
the corresponding data consisted of a Km
of 5.7 µM and a Vmax of 385 pmol/min/mg
protein (fig. 2B); EHBR provided a Km of
44.6 µM and a Vmax of 207 pmol/min/mg protein (fig. 2C).
|
Mutual Effect of the Uptake of DNP-SG and Glucuronide and Sulfate Conjugates
We investigated the effect of the glucuronide and sulfate
conjugates of E3040 (E-glu, E-sul) and 4-methylumbelliferone (4 MUG, 4 MUS) on the uptake of [3H]DNP-SG, a typical
substrate for cMOAT, using CMV from SD rats. Glucuronides (E-glu,
4-MUG) inhibited the uptake of [3H]DNP-SG in a
concentration-dependent manner, whereas sulfates (E-sul, 4-MUS) did
not, although enhancement of [3H]DNP-SG uptake
was observed (fig. 3).
|
In addition, we examined the mutual inhibition of the ATP-dependent DNP-SG and E-glu uptake by CMV from SD rats (fig. 4). Although E-glu also inhibited the ATP-dependent uptake of [14C]E-glu and [3H]DNP-SG in a concentration-dependent manner (fig. 4B), DNP-SG inhibited ATP-dependent [14C]E-glu uptake by only 70% even at 300 µM of the normalized concentration according to Eq. 8, while it inhibited its own uptake almost completely (fig. 4A). From equation 2, the Ki of E-glu for [3H]DNP-SG uptake was calculated as 3.84 µM and the Ki of DNP-SG for [14C]E-glu uptake was 17.1 µM.
The effect of DNP-SG on the ATP-dependent uptake of
[14C]E-glu by CMV from EHBR was also examined.
No inhibitory effect was observed by DNP-SG on the ATP-dependent uptake
of [14C]E-glu (fig.
5). Furthermore, TCA, a bile acid, had no
inhibitory effect on the ATP-dependent uptake of
[14C]E-glu by CMV from either SD rats or EHBR
(fig. 6). TCA rather increased the
ATP-dependent uptake of [14C]E-glu by CMV from
SD rats (fig. 6).
|
|
Because glucuronides and sulfates have different effects on the uptake of [3H]DNP-SG by CMV from SD rats (fig. 3), a kinetic analysis of these effects was performed. The concentration-dependence of ATP-dependent [3H]DNP-SG uptake in the presence and absence of E-glu (30 µM) or E-sul (100 µM) was investigated (fig. 7). In the presence of E-glu, the apparent Km (Kmapp) increased, whereas the Vmax showed only a minimal change (table 1), which suggests competitive inhibition. The E-glu Ki for ATP-dependent uptake of [3H]DNP-SG was calculated to be 11.6 µM by equation 3. By contrast, in the presence of E-sul, the apparent Km (Kmapp) value fell by one third, whereas the Vmax fell by a half (table 1).
| |
Discussion |
|---|
|
|
|---|
Biliary excretion is an important route for the elimination of
organic anions, and mutant rat strains with conjugated
hyperbilirubinemia (TR
, EHBR) exhibit impaired
biliary excretion involving cMOAT and its non-bile acid organic anion
substrates. In these mutant rats, P-glycoprotein and the primary active
transport system for bile acids remain normal (Jansen et
al., 1987a
, b; Kitamura et al., 1990
; Nishida et
al., 1992a
, b). In vivo studies with the Wistar-derived transport mutant rat strain TR
show that the
biliary excretion of organic anions, such as
LTC4, is dramatically reduced after intravenous
administration (Huber et al., 1987
). The mutant SD rat
strain (EHBR) also exhibits a reduced biliary excretion of organic
anions (Fernandez-Checa et al., 1992
; Sathirakul et
al., 1993
). Furthermore, the transport of organic anions across
the bile canalicular membrane has been characterized in
vitro with CMV and the uptake of non-bile acid organic anions,
such as BSP (Kitamura et al., 1990
) and
LTC4 (Ishikawa et al., 1990
;
Sathirakul et al., 1994
), into CMV from normal rats has been
found to be stimulated by ATP, whereas no such enhancement is observed
in CMV from mutant rats (TR
, EHBR). These
studies directly show that both TR
and EHBR
lack the primary active transport system for organic anions which is
directly coupled with ATP-hydrolysis, and also that both mutant rat
strains possess similar characteristics in terms of the hepatobiliary
excretion of ligands. Various organic anions have been recognized by
cMOAT (Fernandez-Checa et al., 1992
; Sathirakul et
al., 1993
; Ishikawa et al., 1990
; Sathirakul et
al., 1994
; Yamazaki et al., 1996
).
E-glu is considered to be transported predominantly by cMOAT, because
its biliary excretion is also severely impaired in EHBR (Takenaka
et al., 1995b
). To examine this notion, we performed comparative studies of the uptake of [14C]E-glu
and [3H]DNP-SG, a typical substrate for cMOAT,
into CMV prepared from SD rats and EHBR. The uptake of both
[3H]DNP-SG and
[14C]E-glu into CMV from SD rats was stimulated
by ATP (fig. 1), which suggests the contribution of a primary active
transporter to the biliary excretion of these ligands. In addition,
because the stimulatory effect of ATP on the uptake of
[14C]E-glu into CMV from EHBR was minimal, the
recognition of E-glu by cMOAT was confirmed (Takenaka et
al., 1995a
). However, the existence of an ATP-dependent
transporter other than cMOAT was suggested for E-glu transport because
a slight but significant transport stimulation by ATP was also observed
in EHBR (Takenaka et al., 1995a
). In the present study, we
examined the mutual inhibition of DNP-SG and E-glu with CMV prepared
from SD rats and EHBR to investigate these results in more detail.
[3H]DNP-SG and [14C]E-glu uptake by CMV from SD rats and [14C]E-glu uptake by CMV from EHBR were stimulated by ATP and exhibited saturation (fig. 2), which confirms that both compounds are excreted into bile by primary active transporters.
In the presence of a fixed concentration of E-glu (30 µM), the apparent Km (Kmapp) for the ATP-dependent uptake of [3H]DNP-SG was found to be 56.8 µM, which is higher than the Km (15.8 µM) when E-glu is not present, whereas the Vmax is not very different from that in the absence of E-glu (fig. 7, table 1). The Ki of E-glu for ATP-dependent [3H]DNP-SG uptake calculated from these data (equation 3) is 11.6 µM, which is similar to its own Km value, 5.7 µM (table 1). In addition, the Ki of DNP-SG for ATP-dependent [14C]E-glu uptake was calculated to be 17.1 µM (fig. 4A), which is also similar to the Km (17.6 µM) for ATP-dependent [3H]DNP-SG uptake (table 1), which indicates that both DNP-SG and E-glu may act mutually and competitively to inhibit the uptake of [3H]DNP-SG and [14C]E-glu; in other words, both compounds share the common transporter at least partially.
The possibility that both these compounds share the transporter is
clearly demonstrated when the data are summarized as in figure 4.
Although E-glu inhibits the ATP-dependent uptake of [14C]E-glu and
[3H]DNP-SG in the same manner and almost
completely inhibits their uptake at its normalized concentration of 300 to 500 µM (fig. 4B), DNP-SG does not inhibit ATP-dependent
[14C]E-glu uptake completely and about
one-third of the uptake remained even at a normalized DNP-SG
concentration of 300 µM, whereas the ATP-dependent uptake of
[3H]DNP-SG itself was almost completely
inhibited (fig. 4A). These mutual inhibition studies suggest that
DNP-SG inhibits the ATP-dependent uptake of E-glu only partially. In
other words, DNP-SG shares part of the transporter(s) for E-glu and
another transporter also contributes to E-glu transport (fig.
8).
|
The unidentified transporter for E-glu, which is also present in EHBR,
is considered to be different from that for DNP-SG, because DNP-SG does
not inhibit the ATP-dependent uptake of
[14C]E-glu by CMV from EHBR (fig. 5). This is
in agreement with the fact that the ATP-dependent uptake of
[3H]DNP-SG by CMV from EHBR is negligible
(Takenaka et al., 1995a
). Moreover, this transporter for
E-glu is different from the bile acid transporter, because the
ATP-dependent uptake of [14C]E-glu by CMV from
EHBR is not inhibited by TCA at a concentration of 300 µM (more than
10 times higher than its own Km, 6.5 µM) (fig. 6).
Previously, we reported that the biliary excretion of E-sul is similar
in both SD rats and EHBR (Takenaka et al., 1995b
). Moreover,
the uptake of E-sul into CMV is similar in SD rats and EHBR and is not
stimulated by ATP (Takenaka et al., 1995a
). Consequently, we
examined the effect of E-sul on the uptake of DNP-SG by CMV. The
ATP-dependent uptake of DNP-SG by CMV was enhanced by E-sul (fig. 3).
This enhancement was also observed with 4 MUS (fig. 3) and was common
to both sulfates. Furthermore, in the presence of E-sul (100 µM), the
apparent Km
(Kmapp) value for the
ATP-dependent uptake of DNP-SG by CMV fell by about one third and the
Vmax fell by about one half (fig. 6), which
suggests that the enhancement of DNP-SG uptake by sulfates mainly is a
result of increased affinity for the transporter, possibly involving a
conformational change.
Based on these observations, we can propose a hypothesis as shown in figure 8 where in cMOAT, which is present in SD rats and is deficient in EHBR, recognizes both DNP-SG and E-glu as substrates. In addition, another transporter, which also recognizes only E-glu, is present. A transporter which recognizes E-glu in EHBR also exists, but at present, it is not clear whether this is the same as that in SD rats. The Km value for ATP-dependent E-glu uptake by CMV from EHBR was about 44.6 µM, which is approximately 8-fold higher than that from SD rats (table 1). It should be noted that the standard deviation of the Km for ATP-dependent E-glu uptake by CMV from SD rats was high, because the lowest practical substrate concentration used was 7.5 µM because of the low specific activity of [14C]E-glu. To more precisely determine the Km value, it would be necessary to have a substrate concentration much lower than the Km (5.7 µM). However, it may be judged from the Eadie-Hofstee plot (fig. 2C) that there is also a saturable primary active transport system in EHBR. This transporter with lower affinity may also be present in SD rats. But in the present kinetic analysis, this low-affinity component could not be detected, possibly because it may be hidden by the high-affinity component.
Although many organic anions including conjugates have been shown to be
excreted into bile by cMOAT, some recent results have suggested the
existence of a multiplicity of organic anion transporters. For example,
we have performed a kinetic analysis of the effects of DBSP and ICG on
the biliary excretion of LTC4 and found that the
predominant transport system for DBSP was different from that for ICG
based on the fact that the biliary excretion of
LTC4 in SD rats was inhibited by infusion of
DBSP, but not by ICG (Sathirakul et al., 1994
). The biliary
excretion of LG glucuronides (LG-monoglucuronide and
LG-glucuronide-sulfate) is reduced in EHBR, and coadministration of
glycyrrhizin (containing a glucuronide moiety) and DBSP in SD rats
significantly reduces their biliary excretion, but has no effect on the
biliary excretion of the disulfate (Shimamura et al., 1994
).
Moreover, as mentioned above, one of our studies involving the biliary
excretion of E-glu and E-sul also suggests different biliary excretion
mechanisms for glucuronides and sulfates (Takenaka et al.,
1995b
). Kobayashi et al. (1991)
reported that DNP-SG and
LTC4 completely inhibit the ATP-dependent uptake
of NPG by CMV, whereas NPG only inhibits DNP-SG uptake by 80% even at
a concentration of 200 µM (10 times the
Km value of NPG itself).
Support for the presence of several related transporters is emerging
from studies at the molecular level. For example, Paulusma et
al. (1996)
succeeded in cloning the cDNA of cMOAT from Wistar rat
liver, and the amino acid sequence deduced was the same as that cloned
by us in SD rats (Ito et al., 1997
). Northern blot analysis
of poly(A)+ RNA from the liver with the entire
open reading frame of cMOAT as a probe was defective in EHBR. On the
other hand, most recently, we have found the cDNA fragment that was
amplified by use of primers based on the conserved sequence of the
carboxy-terminal ATP-binding cassette region of human multidrug
resistance-associated protein by polymerase chain reaction, and also
hybridized to poly(A)+ RNA from the liver of EHBR
(Hirohashi, T., Suzuki, H., Ito, K., Ogawa, K., Kume, K., Shimizu, T. and Sugiyama, Y., unpublished observation).
In conclusion, the present findings suggest the presence of multiple systems for the primary active transport of organic anions across the bile canalicular membrane; one is the predominant transporter for DNP-SG, the other is a transporter that does not recognize DNP-SG but recognizes E-glu as a substrate and is also present in EHBR.
| |
Footnotes |
|---|
Accepted for publication April 8, 1997.
Received for publication September 4, 1996.
1 This study was supported in part by a Grant-in Aid for Scientific Research provided by the Ministry of Education, Science and Culture of Japan.
Send reprint requests to: Yuichi Sugiyama, Ph.D., Professor and Chair, Faculty of Pharmaceutical Sciences, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113, Japan.
| |
Abbreviations |
|---|
DNP-SG, S-(2,4-dinitrophenyl)-glutathione; EHBR, Eisai hyperbilirubinemic rat; cMOAT, canalicular multispecific organic anion transporter; CMV, canalicular membrane vesicles; SD rat, Sprague-Dawley rat; E3040, 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole; E-glu, E3040-glucuronide; E-sul, E3040-sulfate; 4 MU, 4-methylumbelliferone; 4 MUG, 4 MU-glucuronide; 4 MUS, 4 MU-sulfate; LTC4, leukotriene C4; BSP, sulfobromophthalein; DBSP, dibromosulfophthalein; ICG, indocyanine green; LG, Liquiritigenin; Km, Michaelis constant; Vmax, maximum transport velocity; Pdif, nonspecific diffusion clearance; Ki, inhibitory constant; TCA, taurocholate; NPG, p-nitrophenyl glucuronide.
| |
References |
|---|
|
|
|---|
-diphosphate glucuronyl-transferase deficiency.
Gastroenterology
93: 1094-1103, 1987b[Medline].
) rats with conjugated hyperbilirubinemia.
Proc. Natl. Acad. Sci. U.S.A.
87: 3557-3561, 1990
) with inherited conjugated hyperbilirubinemia.
J. Clin. Invest.
90: 2130-2135, 1992a.This article has been cited by other articles:
![]() |
M. Ninomiya, K. Ito, and T. Horie FUNCTIONAL ANALYSIS OF DOG MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2) IN COMPARISON WITH RAT MRP2 Drug Metab. Dispos., February 1, 2005; 33(2): 225 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takada, H. M. Weiss, O. Kretz, G. Gross, and Y. Sugiyama HEPATIC TRANSPORT OF PKI166, AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR OF THE PYRROLO-PYRIMIDINE CLASS, AND ITS MAIN METABOLITE, ACU154 Drug Metab. Dispos., November 1, 2004; 32(11): 1272 - 1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mizuno, M. Suzuki, H. Kusuhara, H. Suzuki, K. Takeuchi, T. Niwa, J. W. Jonker, and Y. Sugiyama IMPAIRED RENAL EXCRETION OF 6-HYDROXY-5,7-DIMETHYL-2-METHYLAMINO-4-(3-PYRIDYLMETHYL) BENZOTHIAZOLE (E3040) SULFATE IN BREAST CANCER RESISTANCE PROTEIN (BCRP1/ABCG2) KNOCKOUT MICE Drug Metab. Dispos., September 1, 2004; 32(9): 898 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-S. Chen, R. W. Robey, M. G. Belinsky, I. Shchaveleva, X.-Q. Ren, Y. Sugimoto, D. D. Ross, S. E. Bates, and G. D. Kruh Transport of Methotrexate, Methotrexate Polyglutamates, and 17{beta}-Estradiol 17-({beta}-D-glucuronide) by ABCG2: Effects of Acquired Mutations at R482 on Methotrexate Transport Cancer Res., July 15, 2003; 63(14): 4048 - 4054. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suzuki, H. Suzuki, Y. Sugimoto, and Y. Sugiyama ABCG2 Transports Sulfated Conjugates of Steroids and Xenobiotics J. Biol. Chem., June 13, 2003; 278(25): 22644 - 22649. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sasaki, H. Suzuki, K. Ito, T. Abe, and Y. Sugiyama Transcellular Transport of Organic Anions Across a Double-transfected Madin-Darby Canine Kidney II Cell Monolayer Expressing Both Human Organic Anion-transporting Polypeptide (OATP2/SLC21A6) and Multidrug Resistance-associated Protein 2 (MRP2/ABCC2) J. Biol. Chem., February 15, 2002; 277(8): 6497 - 6503. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ito, H. Suzuki, and Y. Sugiyama Single amino acid substitution of rat MRP2 results in acquired transport activity for taurocholate Am J Physiol Gastrointest Liver Physiol, October 1, 2001; 281(4): G1034 - G1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Han, Y. Kato, Y. Watanabe, K. Terao, Y. Asoh, and Y. Sugiyama Carrier-Mediated Hepatobiliary Transport of a Novel Antifolate, N-[4-[(2,4-Diamminopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-Homoglutamic Acid, in Rats Drug Metab. Dispos., April 1, 2001; 29(4): 394 - 400. [Abstract] [Full Text] |
||||
![]() |
L. Sabordo, B. C. Sallustio, A. M. Evans, and R. L. Nation Hepatic Disposition of the Acyl Glucuronide 1-O-Gemfibrozil-beta -D-glucuronide: Effects of Clofibric Acid, Acetaminophen, and Acetaminophen Glucuronide J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 44 - 50. [Abstract] [Full Text] |
||||
![]() |
R. A. M. H. Van Aubel, R. Masereeuw, and F. G. M. Russel Molecular pharmacology of renal organic anion transporters Am J Physiol Renal Physiol, August 1, 2000; 279(2): F216 - F232. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hirohashi, H. Suzuki, H. Takikawa, and Y. Sugiyama ATP-dependent Transport of Bile Salts by Rat Multidrug Resistance-associated Protein 3 (Mrp3) J. Biol. Chem., January 28, 2000; 275(4): 2905 - 2910. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hirohashi, H. Suzuki, X.-Y. Chu, I. Tamai, A. Tsuji, and Y. Sugiyama Function and Expression of Multidrug Resistance-Associated Protein Family in Human Colon Adenocarcinoma Cells (Caco-2) J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 265 - 270. [Abstract] [Full Text] |
||||
![]() |
T. Hirohashi, H. Suzuki, and Y. Sugiyama Characterization of the Transport Properties of Cloned Rat Multidrug Resistance-associated Protein 3 (MRP3) J. Biol. Chem., May 21, 1999; 274(21): 15181 - 15185. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Niinuma, Y. Kato, H. Suzuki, C. A. Tyson, V. Weizer, J. E. Dabbs, R. Froehlich, C. E. Green, and Y. Sugiyama Primary active transport of organic anions on bile canalicular membrane in humans Am J Physiol Gastrointest Liver Physiol, May 1, 1999; 276(5): G1153 - G1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Akhteruzzaman, Y. Kato, A. Hisaka, and Y. Sugiyama Primary Active Transport of Peptidic Endothelin Antagonists by Rat Hepatic Canalicular Membrane J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 575 - 581. [Abstract] [Full Text] |
||||